Search research articles
Contact Us
Filters
Showing results (711-720 of 734) with videos related to
Page
of 74
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
Quantitative dissection of the metastatic cascade at single colony resolution
Chris Roberts, Andy Xu, Xiangwei Fang, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 1999
A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors
C S Li, W C Black, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors
R W Friesen, C Brideau, C C Chan, et al.
Disability and Rehabilitation
|
February 9, 2024
Effects of mirror therapy with electrical stimulation for upper limb recovery in people with stroke: a systematic review and meta-analysis
Hong Pan, Tai Wa Liu, Shamay S M Ng, et al.
Plos Pathogens
|
October 14, 2016
Identification of Novel Rosavirus Species That Infects Diverse Rodent Species and Causes Multisystemic Dissemination in Mouse Model
Susanna K P Lau, Patrick C Y Woo, Kenneth S M Li, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability
D Delorme, Y Ducharme, C Brideau, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice
G Lambert, N Sakai, B L Vaisman, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 29, 2000
Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx)
D A Nicoll-Griffith, J A Yergey, L A Trimble, et al.
Journal of Medicinal Chemistry
|
August 29, 1997
Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010
P Hamel, D Riendeau, C Brideau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
Duc Tran, J Scott Beeler, Jie Liu, et al.
Page
of 74
Search research articles
Search
Showing results (711-720 of 734) with videos related to
Sort By:
Page
of 74
Biorxiv : the Preprint Server for Biology
|
May 13, 2026
Quantitative dissection of the metastatic cascade at single colony resolution
Chris Roberts, Andy Xu, Xiangwei Fang, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 1999
A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors
C S Li, W C Black, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors
R W Friesen, C Brideau, C C Chan, et al.
Disability and Rehabilitation
|
February 9, 2024
Effects of mirror therapy with electrical stimulation for upper limb recovery in people with stroke: a systematic review and meta-analysis
Hong Pan, Tai Wa Liu, Shamay S M Ng, et al.
Plos Pathogens
|
October 14, 2016
Identification of Novel Rosavirus Species That Infects Diverse Rodent Species and Causes Multisystemic Dissemination in Mouse Model
Susanna K P Lau, Patrick C Y Woo, Kenneth S M Li, et al.
Journal of Medicinal Chemistry
|
September 27, 1996
Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability
D Delorme, Y Ducharme, C Brideau, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice
G Lambert, N Sakai, B L Vaisman, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 29, 2000
Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx)
D A Nicoll-Griffith, J A Yergey, L A Trimble, et al.
Journal of Medicinal Chemistry
|
August 29, 1997
Substituted (pyridylmethoxy)naphthalenes as potent and orally active 5-lipoxygenase inhibitors; synthesis, biological profile, and pharmacokinetics of L-739,010
P Hamel, D Riendeau, C Brideau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk
Duc Tran, J Scott Beeler, Jie Liu, et al.
Page
of 74